Vision modulation, plasticity and restoration using non-invasive brain stimulation - An IFCN-sponsored review.


Journal

Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology
ISSN: 1872-8952
Titre abrégé: Clin Neurophysiol
Pays: Netherlands
ID NLM: 100883319

Informations de publication

Date de publication:
04 2020
Historique:
received: 18 04 2019
revised: 18 12 2019
accepted: 02 01 2020
pubmed: 23 2 2020
medline: 19 12 2020
entrez: 21 2 2020
Statut: ppublish

Résumé

The visual system has one of the most complex structures of all sensory systems and is perhaps the most important sense for everyday life. Its functional organization was extensively studied for decades in animal and humans, for example by correlating circumscribed anatomical lesions in patients with the resulting visual dysfunction. During the past two decades, significant achievements were accomplished in characterizing and modulating visual information processing using non-invasive stimulation techniques of the normal and damaged human eye and brain. Techniques include transcranial magnetic stimulation (TMS) and low intensity electric stimulation using either direct or alternating currents applied transcranially (tDCS or tACS) near or above the visual cortex, or alternating currents applied transorbitally (trACS). In the case of transorbital stimulation of the visual system the electrodes are attached near the eye, to the eyelids (transpalpebral electrical stimulation - TPES) or the cornea (tanscorneal electrical stimulation TcES). Here, we summarize the state-of-the-art of visual system magnetic and electric stimulation as a method to modulate normal vision, induce brain plasticity, and to restore visual functions in patients. We review this field's history, models of current flow paths in the eye and brain, neurophysiological principles (e.g. entrainment and after-effects), the effects on vision in normal subjects and the clinical impact on plasticity and vision restoration in patients with low vision, with a particular focus on "off-line" or "after-effects". With regard to the therapeutic possibilities, ACS was demonstrated to be effective in patients affected by glaucoma and optic neuropathy, while tDCS and random noise stimulation (tRNS) are most promising for the treatment of amblyopia, hemianopia and myopia. In addition, rTMS applied above the occipital area is a promising approach to treat migraine, neglect and hemianopia. Although the response to these treatment options is better than to sham stimulation in double blinded clinical studies, the clinical efficacy is still rather variable and a proportion of patients do not respond. It is therefore imperative to better understand the mechanisms of action to be able to optimize treatment protocols possibly through personalization of brain stimulation protocols. By identifying the current opportunities and challenges in the field, we hope to provide insights to help improve neuromodulation protocols to restore visual function in patients with visual system damage.

Identifiants

pubmed: 32078919
pii: S1388-2457(20)30035-3
doi: 10.1016/j.clinph.2020.01.008
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

887-911

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

Copyright © 2020 International Federation of Clinical Neurophysiology. Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest We would like to declare that B.A. Sabel is shareholder of a vision rehabilitation day clinic. The other authors have no conflicts of interest, financial or otherwise, and all concur with the conditions of submission of the manuscript in the present form.

Auteurs

Bernhard A Sabel (BA)

Institute of Medical Psychology, Otto-von-Guericke University Magdeburg, Magdeburg, Germany. Electronic address: bernhard.sabel@med.ovgu.de.

Gregor Thut (G)

Institute of Neuroscience and Psychology, University of Glasgow, United Kingdom.

Jens Haueisen (J)

Institute of Biomedical Engineering and Informatics, Technische Universität Ilmenau, Ilmenau, Germany.

Petra Henrich-Noack (P)

Institute of Medical Psychology, Otto-von-Guericke University Magdeburg, Magdeburg, Germany; Clinic of Neurology with Institute of Translational Neurology, University Clinic Münster, Münster, Germany.

Christoph S Herrmann (CS)

Experimental Psychology Lab, Department of Psychology, Cluster for Excellence "Hearing for All", European Medical School, Carl von Ossietzky University, Oldenburg, Germany; Research Center Neurosensory Science, Carl von Ossietzky University Oldenburg, Germany.

Alexander Hunold (A)

Institute of Biomedical Engineering and Informatics, Technische Universität Ilmenau, Ilmenau, Germany.

Thomas Kammer (T)

Department of Psychiatry, University of Ulm, Germany.

Barbara Matteo (B)

SAVIR Center, Magdeburg, Germany; Department of Medicine and Surgery, University of Milan-Bicocca, Italy.

Elena G Sergeeva (EG)

Department of Neurology, Boston Children's Hospital, Harvard Medical School, USA.

Wioletta Waleszczyk (W)

Nencki Institute of Experimental Biology, Polish Academy of Sciences, Warsaw, Poland.

Andrea Antal (A)

Institute of Medical Psychology, Otto-von-Guericke University Magdeburg, Magdeburg, Germany; Department of Clinical Neurophysiology, University Medical Center Göttingen, Göttingen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH